EDITAS MEDICINE INC (EDIT) insider trading activity (SEC Form 4). Over the trailing 90 days, EDIT insiders filed 0 purchases totalling $0 and 5 sales totalling $60K — net SELLING of $60K. Most recent filing: Aug 5, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Parison Amy | SVP, CFO | S Sale | — | $2.58 | $2K | filing |
| Jul 29, 2026 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S Sale | — | $2.67 | $13K | filing |
| Jun 5, 2026 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S Sale | — | $2.70 | $2K | filing |
| Jun 5, 2026 | O'Neill Gilmore Neil | CEO | S Sale | — | $2.70 | $42K | filing |
| Jun 5, 2026 | Parison Amy | SVP, CFO | S Sale | — | $2.70 | $1K | filing |